Effects of intraoperative use of the topical hemostatic matrix agent, Floseal, in primary unilateral total knee arthroplasty

David A. Liebelt, Benjamin J. Levy, Praveen K. Kadimcher, Jonathan D. Krystal, Robert Li, Ajay Lall, Yossef C. Blum, David M. Hirsh, Sun Jin Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Total knee arthroplasty can result in blood loss severe enough to require postoperative blood transfusions. Minimizing blood loss perioperatively is therefore essential to minimize morbidity in patients undergoing total knee arthroplasty. Floseal (Baxter International, Inc., Deerfield, IL) is a topical hemostatic matrix agent used for hemostasis during surgical operations. Methods: Patients undergoing routine total knee arthroplasty were randomized into two groups. One group received intraoperative standard hemostatic therapy and another group received intraoperative standard hemostatic therapy as well as Floseal. The groups were compared based on 24-hour postoperative drain output, 3-day postoperative drop in hematocrit and hemoglobin levels, and the incidence of postoperative transfusions. Results: One hundred and forty patients with primary unilateral total knee arthroplasties were recruited and 70 were randomized to the control group and 70 to the Floseal group. The mean 24- hour postoperative drain output for patients in the control group was 457.1 (-28.60) mL compared with 405.0 (-22.93) mL in the Floseal group. This difference was not significant (P=0.1651). Comparison of 3-day postoperative drops in hemoglobin and hematocrit values between the control and experimental groups also demonstrated no statistical significance (P=0.5422 and P=0.6524, respectively). The incidences of postoperative blood transfusions based on intraoperative use of Floseal were not significantly different (P=0.4389). Perioperative complications and their rates were not found to be changed with the intraoperative use of Floseal. Conclusions: Our data suggest that there is no benefit from the regular use of Floseal in routine total knee arthroplasty. Intraoperative use of Floseal in total knee arthroplasty did not increase complications and can likely be used safely.

Original languageEnglish (US)
Pages (from-to)509-512
Number of pages4
JournalCurrent Orthopaedic Practice
Volume24
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Knee Replacement Arthroplasties
Hemostatics
Hematocrit
Blood Transfusion
Control Groups
Hemoglobins
Incidence
Group Psychotherapy
Hemostasis
FloSeal Matrix
Morbidity

Keywords

  • Blood loss
  • Floseal
  • Topical hemostatic matrix
  • Total knee arthroplasty
  • Transfusion

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Effects of intraoperative use of the topical hemostatic matrix agent, Floseal, in primary unilateral total knee arthroplasty. / Liebelt, David A.; Levy, Benjamin J.; Kadimcher, Praveen K.; Krystal, Jonathan D.; Li, Robert; Lall, Ajay; Blum, Yossef C.; Hirsh, David M.; Kim, Sun Jin.

In: Current Orthopaedic Practice, Vol. 24, No. 5, 09.2013, p. 509-512.

Research output: Contribution to journalArticle

Liebelt, David A. ; Levy, Benjamin J. ; Kadimcher, Praveen K. ; Krystal, Jonathan D. ; Li, Robert ; Lall, Ajay ; Blum, Yossef C. ; Hirsh, David M. ; Kim, Sun Jin. / Effects of intraoperative use of the topical hemostatic matrix agent, Floseal, in primary unilateral total knee arthroplasty. In: Current Orthopaedic Practice. 2013 ; Vol. 24, No. 5. pp. 509-512.
@article{1a037425ac1844dcb690fefca0210942,
title = "Effects of intraoperative use of the topical hemostatic matrix agent, Floseal, in primary unilateral total knee arthroplasty",
abstract = "Background: Total knee arthroplasty can result in blood loss severe enough to require postoperative blood transfusions. Minimizing blood loss perioperatively is therefore essential to minimize morbidity in patients undergoing total knee arthroplasty. Floseal (Baxter International, Inc., Deerfield, IL) is a topical hemostatic matrix agent used for hemostasis during surgical operations. Methods: Patients undergoing routine total knee arthroplasty were randomized into two groups. One group received intraoperative standard hemostatic therapy and another group received intraoperative standard hemostatic therapy as well as Floseal. The groups were compared based on 24-hour postoperative drain output, 3-day postoperative drop in hematocrit and hemoglobin levels, and the incidence of postoperative transfusions. Results: One hundred and forty patients with primary unilateral total knee arthroplasties were recruited and 70 were randomized to the control group and 70 to the Floseal group. The mean 24- hour postoperative drain output for patients in the control group was 457.1 (-28.60) mL compared with 405.0 (-22.93) mL in the Floseal group. This difference was not significant (P=0.1651). Comparison of 3-day postoperative drops in hemoglobin and hematocrit values between the control and experimental groups also demonstrated no statistical significance (P=0.5422 and P=0.6524, respectively). The incidences of postoperative blood transfusions based on intraoperative use of Floseal were not significantly different (P=0.4389). Perioperative complications and their rates were not found to be changed with the intraoperative use of Floseal. Conclusions: Our data suggest that there is no benefit from the regular use of Floseal in routine total knee arthroplasty. Intraoperative use of Floseal in total knee arthroplasty did not increase complications and can likely be used safely.",
keywords = "Blood loss, Floseal, Topical hemostatic matrix, Total knee arthroplasty, Transfusion",
author = "Liebelt, {David A.} and Levy, {Benjamin J.} and Kadimcher, {Praveen K.} and Krystal, {Jonathan D.} and Robert Li and Ajay Lall and Blum, {Yossef C.} and Hirsh, {David M.} and Kim, {Sun Jin}",
year = "2013",
month = "9",
doi = "10.1097/BCO.0b013e31829c4476",
language = "English (US)",
volume = "24",
pages = "509--512",
journal = "Current Orthopaedic Practice",
issn = "1940-7041",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effects of intraoperative use of the topical hemostatic matrix agent, Floseal, in primary unilateral total knee arthroplasty

AU - Liebelt, David A.

AU - Levy, Benjamin J.

AU - Kadimcher, Praveen K.

AU - Krystal, Jonathan D.

AU - Li, Robert

AU - Lall, Ajay

AU - Blum, Yossef C.

AU - Hirsh, David M.

AU - Kim, Sun Jin

PY - 2013/9

Y1 - 2013/9

N2 - Background: Total knee arthroplasty can result in blood loss severe enough to require postoperative blood transfusions. Minimizing blood loss perioperatively is therefore essential to minimize morbidity in patients undergoing total knee arthroplasty. Floseal (Baxter International, Inc., Deerfield, IL) is a topical hemostatic matrix agent used for hemostasis during surgical operations. Methods: Patients undergoing routine total knee arthroplasty were randomized into two groups. One group received intraoperative standard hemostatic therapy and another group received intraoperative standard hemostatic therapy as well as Floseal. The groups were compared based on 24-hour postoperative drain output, 3-day postoperative drop in hematocrit and hemoglobin levels, and the incidence of postoperative transfusions. Results: One hundred and forty patients with primary unilateral total knee arthroplasties were recruited and 70 were randomized to the control group and 70 to the Floseal group. The mean 24- hour postoperative drain output for patients in the control group was 457.1 (-28.60) mL compared with 405.0 (-22.93) mL in the Floseal group. This difference was not significant (P=0.1651). Comparison of 3-day postoperative drops in hemoglobin and hematocrit values between the control and experimental groups also demonstrated no statistical significance (P=0.5422 and P=0.6524, respectively). The incidences of postoperative blood transfusions based on intraoperative use of Floseal were not significantly different (P=0.4389). Perioperative complications and their rates were not found to be changed with the intraoperative use of Floseal. Conclusions: Our data suggest that there is no benefit from the regular use of Floseal in routine total knee arthroplasty. Intraoperative use of Floseal in total knee arthroplasty did not increase complications and can likely be used safely.

AB - Background: Total knee arthroplasty can result in blood loss severe enough to require postoperative blood transfusions. Minimizing blood loss perioperatively is therefore essential to minimize morbidity in patients undergoing total knee arthroplasty. Floseal (Baxter International, Inc., Deerfield, IL) is a topical hemostatic matrix agent used for hemostasis during surgical operations. Methods: Patients undergoing routine total knee arthroplasty were randomized into two groups. One group received intraoperative standard hemostatic therapy and another group received intraoperative standard hemostatic therapy as well as Floseal. The groups were compared based on 24-hour postoperative drain output, 3-day postoperative drop in hematocrit and hemoglobin levels, and the incidence of postoperative transfusions. Results: One hundred and forty patients with primary unilateral total knee arthroplasties were recruited and 70 were randomized to the control group and 70 to the Floseal group. The mean 24- hour postoperative drain output for patients in the control group was 457.1 (-28.60) mL compared with 405.0 (-22.93) mL in the Floseal group. This difference was not significant (P=0.1651). Comparison of 3-day postoperative drops in hemoglobin and hematocrit values between the control and experimental groups also demonstrated no statistical significance (P=0.5422 and P=0.6524, respectively). The incidences of postoperative blood transfusions based on intraoperative use of Floseal were not significantly different (P=0.4389). Perioperative complications and their rates were not found to be changed with the intraoperative use of Floseal. Conclusions: Our data suggest that there is no benefit from the regular use of Floseal in routine total knee arthroplasty. Intraoperative use of Floseal in total knee arthroplasty did not increase complications and can likely be used safely.

KW - Blood loss

KW - Floseal

KW - Topical hemostatic matrix

KW - Total knee arthroplasty

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=84884497698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884497698&partnerID=8YFLogxK

U2 - 10.1097/BCO.0b013e31829c4476

DO - 10.1097/BCO.0b013e31829c4476

M3 - Article

AN - SCOPUS:84884497698

VL - 24

SP - 509

EP - 512

JO - Current Orthopaedic Practice

JF - Current Orthopaedic Practice

SN - 1940-7041

IS - 5

ER -